West PharmaceuticalWST
WST
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
150% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 10 (+6) [Q4]
26% more first-time investments, than exits
New positions opened: 101 | Existing positions closed: 80
12% more repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 256
11% more capital invested
Capital invested by funds: $20.5B [Q3] → $22.8B (+$2.27B) [Q4]
1.33% more ownership
Funds ownership: 94.64% [Q3] → 95.98% (+1.33%) [Q4]
1% more funds holding
Funds holding: 720 [Q3] → 728 (+8) [Q4]
44% less call options, than puts
Call options by funds: $77.4M | Put options by funds: $139M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$275
25%
upside
Avg. target
$333
51%
upside
High target
$400
82%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Evercore ISI Group Daniel Markowitz 0% 1-year accuracy 0 / 2 met price target | 25%upside $275 | Outperform Initiated | 18 Mar 2025 |
Keybanc Paul Knight 22% 1-year accuracy 2 / 9 met price target | 48%upside $325 | Overweight Maintained | 14 Feb 2025 |
Citigroup Thomas Palmer 25% 1-year accuracy 8 / 32 met price target | 82%upside $400 | Buy Initiated | 8 Jan 2025 |
Financial journalist opinion
Based on 23 articles about WST published over the past 30 days
Neutral
Accesswire
8 hours ago
Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Positive
Seeking Alpha
1 day ago
Best Dividend Aristocrats For April 2025
Dividend Aristocrats are outperforming the S&P 500 in 2025, demonstrating resilience, with NOBL up 1.78% YTD versus SPY's 4.9% decline. Top performers include Consolidated Edison (+22.98%), Brown & Brown (+20.65%), and AbbVie (+16.61%), showcasing strong double-digit gains. 29 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.15%.

Neutral
Accesswire
1 day ago
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
4 days ago
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
5 days ago
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
6 days ago
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
1 week ago
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
1 week ago
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST
NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
1 week ago
Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Neutral
Accesswire
1 week ago
West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.

Charts implemented using Lightweight Charts™